Safety and Survival Outcomes of 177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior 223Ra treatment: The RALU Study

DSpace Repository

Safety and Survival Outcomes of 177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior 223Ra treatment: The RALU Study

Author: Rahbar, Kambiz; Essler, Markus; Pabst, Kim M.; Eiber, Matthias; la Fouge, Christian; Prasad, Vikas; Rassek, Philipp; Hasa, Ergela; Dittmann, Helmut; Bundschuh, Ralph A.; Fendler, Wolfgang P.; Kurtinecz, Milena; Schmall, Anja; Verholen, Frank; Sartor, Oliver
Tübinger Autor(en):
Dittmann, Helmut
La Fougère, Christian Jean
Published in: Journal of Nuclear Medicine (2023), Bd. 64, H. 4, S. 574-578
Verlagsangabe: Reston : Soc Nuclear Medicine Inc
Language: English
Full text: http://dx.doi.org/10.2967/jnumed.122.264456
ISSN: 0161-5505
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)